Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesNew Anti-Rejection Drug Saves Money, Lives
Ivanhoe, 10/16/09
A newer, less expensive drug used to prevent organ rejection has been shown to be equally as effective and safe as its more expensive counterpart. In a study researchers compared the effectiveness of two drugs used to reduce the chances of rejection in kidney and pancreas transplants: alemtuzumab, a new drug that costs about $1,000 per treatment, and rabbit antithymocyte globulin, which costs about four times as much. Both drugs are used in short–term treatment to rapidly lower the immune system and thus prevent organ rejection.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
New computer model could lead to safer stents
ScienceDaily, 12/03/09
Half of worlds ICU patients have infections
Reuters, 12/03/09
Beverage Can Tabs Still Dangerous
Ivanhoe, 12/02/09
Sponsor
Article Search
Sponsor